Concepedia

Holly LaDuca

HL

Statistics

Publications

52

Citations

4.7K

H-Index

35

Active since

2009

Affiliations

Ambry Genetics (United States)(Current)

University of California, Irvine

Mayo Clinic in Arizona

University of Utah

Dana-Farber Cancer Institute

Holly LaDuca is an author at Ambry Genetics (United States) specializing in genetics, cancer genetics, and oncology.

ORCID

Publications per year

2009–2023

52

Publications

52

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

Fergus J. Couch, Hermela Shimelis, Chunling Hu et al. · JAMA Oncology · 2017 · 627 citations · Full text

, , +17

Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk et al. · Journal of Clinical Oncology · 2019 · 418 citations · Full text

, , +17

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients

Holly LaDuca, Aaron J. Stuenkel, Jill S. Dolinsky et al. · Genetics in Medicine · 2014 · 337 citations · Full text

, , +17

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing

Hermela Shimelis, Holly LaDuca, Chunling Hu et al. · JNCI Journal of the National Cancer Institute · 2018 · 328 citations · Full text

, , +17

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care

Stephany Tandy-Connor, Jenna Guiltinan, Kate Krempely et al. · Genetics in Medicine · 2018 · 271 citations · Full text

, , +15

1–5 of 52